With the next DSMB statement due to come out in the next few days and hopefully not hearing from the FDA on the Kidney trial application before the 25th of March, I hope we don't see the MD&A until after these events. They have 60 days after the quarter to file. If they wait for these two events to happen, both would be material subsequent events to include on this MD&A that would be there to view for anyone looking at them for the next 3 months following the disclosure.

Who knows, there may even be a financing before the end of the month?

tada